NCT03253536View on ClinicalTrials.gov

Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 10, 2017

Primary Completion Date

July 10, 2022

Study Completion Date

July 10, 2027

Conditions
Hepatocellular CancerQuality of LifeStereotactic Body Radiation TherapyObservational
Interventions
OTHER

observational

none (observational study)

Trial Locations (1)

81377

RECRUITING

Department of Radiation Oncology, University Hospital, LMU Munich, Munich

All Listed Sponsors
lead

Ludwig-Maximilians - University of Munich

OTHER

NCT03253536 - Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter